158 related articles for article (PubMed ID: 34916704)
1. [Long-term rituximab treatment of refractory idiopathic inflammatory myopathy: A report of 3 cases].
Yi WX; Wei CJ; Wu Y; Bao XH; Xiong H; Chang XZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1191-1195. PubMed ID: 34916704
[TBL] [Abstract][Full Text] [Related]
2. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
[TBL] [Abstract][Full Text] [Related]
3. Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
Miller T; Al-Lozi MT; Lopate G; Pestronk A
J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):420-8. PubMed ID: 12235311
[TBL] [Abstract][Full Text] [Related]
4. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy.
Dandasena T; Ingle V; Singhai A; Saigal S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081733
[TBL] [Abstract][Full Text] [Related]
5. Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.
Binns EL; Moraitis E; Maillard S; Tansley S; McHugh N; Jacques TS; Wedderburn LR; Pilkington C; Yasin SA; Nistala K;
Pediatr Rheumatol Online J; 2017 Oct; 15(1):77. PubMed ID: 29089059
[TBL] [Abstract][Full Text] [Related]
6. The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies.
Xu Q; Li QX; Bi FF; Duan HQ; Luo YB; Yang H
Clin Rheumatol; 2021 Feb; 40(2):613-624. PubMed ID: 32671659
[TBL] [Abstract][Full Text] [Related]
7. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
Nóvoa Medina FJ; Gutiérrez Martínez J; González González Y; Romero Díaz B; Machín García S; Rosas Romero A
Reumatol Clin (Engl Ed); 2018; 14(6):379-381. PubMed ID: 28389200
[TBL] [Abstract][Full Text] [Related]
8. Severe onset of inflammatory myositis in a child: think to paraneoplastic myositis.
Benvenuto S; Gortani G; Bussani R; Poropat F; Murru FM; Carrozzi M; Tommasini A; Taddio A
Ital J Pediatr; 2021 Jul; 47(1):146. PubMed ID: 34210321
[TBL] [Abstract][Full Text] [Related]
9. Anti-SRP immune-mediated necrotizing myopathy responsive to ofatumumab: a case report.
Chen S; Yang J; He D; Fu J; Lai X; Zhao B; Chen X; Shang H
Front Immunol; 2023; 14():1301109. PubMed ID: 38169756
[TBL] [Abstract][Full Text] [Related]
10. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Seronegative Inflammatory Myositis to Dermatomyositis With Characteristic Cutaneous Features: A Case Report.
Jevtic D; Dharmah U; Bahar M
J Investig Med High Impact Case Rep; 2023; 11():23247096231217829. PubMed ID: 38097369
[TBL] [Abstract][Full Text] [Related]
12. [A case of chronic myopathy associated with an antibody to signal recognition particle (SRP) following long-term asymptomatic hypercreatinekinasemia].
Itaya K; Inoue M; Iwanami H; Oonaka Y; Jimi T; Ichikawa H
Rinsho Shinkeigaku; 2015; 55(4):254-8. PubMed ID: 25904255
[TBL] [Abstract][Full Text] [Related]
13. Anti-Ku antibody-positive systemic sclerosis and idiopathic inflammatory myopathies overlap syndrome in children: a report of two cases and a review of the literature.
Kanda S; Shimbo A; Nakamura Y; Matsuno R; Kaneko S; Irabu H; Kaneko K; Shimizu M
Clin Rheumatol; 2023 Dec; 42(12):3411-3417. PubMed ID: 37393558
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series.
Xiong A; Yang G; Song Z; Xiong C; Liu D; Shuai Y; He L; Zhang L; Guo Z; Shuai S
Ther Adv Neurol Disord; 2021; 14():1756286421998918. PubMed ID: 33786066
[TBL] [Abstract][Full Text] [Related]
15. Rituximab as a glucocorticoid-sparing agent in idiopathic inflammatory myopathies: a retrospective single-center cohort study.
Egeli BH; Ergun S; Cetin A; Gursoy YK; Ugurlu S
Clin Rheumatol; 2022 Jan; 41(1):123-127. PubMed ID: 34387760
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Rituximab in Refractory Inflammatory Myopathy Associated With Coexistence of Behçet's Disease and Antiphospholipid Syndrome.
Guiomar V; Oliveira D; Correia C; Pereira E
Eur J Case Rep Intern Med; 2019; 6(11):001294. PubMed ID: 31890711
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature.
Nalotto L; Iaccarino L; Zen M; Gatto M; Borella E; Domenighetti M; Punzi L; Doria A
Immunol Res; 2013 Jul; 56(2-3):362-70. PubMed ID: 23572427
[TBL] [Abstract][Full Text] [Related]
18. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
19. Recovery from hypoxemia and Hypercapnia following noninvasive pressure support ventilation in a patient with statin-associated necrotizing myopathy: a case report.
Yamamura Y; Matsumoto Y; Tadokoro K; Ohta Y; Sato K; Yamashita T; Yamamura M; Sada KE; Abe K; Wada J
BMC Pulm Med; 2020 Jun; 20(1):156. PubMed ID: 32493279
[TBL] [Abstract][Full Text] [Related]
20. Rituximab as an effective alternative therapy in refractory idiopathic inflammatory myopathies.
Muñoz-Beamud F; Isenberg DA
Clin Exp Rheumatol; 2013; 31(6):896-903. PubMed ID: 24050676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
